1. Home
  2. HAE vs PCH Comparison

HAE vs PCH Comparison

Compare HAE & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • PCH
  • Stock Information
  • Founded
  • HAE 1971
  • PCH 1903
  • Country
  • HAE United States
  • PCH United States
  • Employees
  • HAE N/A
  • PCH N/A
  • Industry
  • HAE Medical/Dental Instruments
  • PCH Real Estate Investment Trusts
  • Sector
  • HAE Health Care
  • PCH Real Estate
  • Exchange
  • HAE Nasdaq
  • PCH Nasdaq
  • Market Cap
  • HAE 3.3B
  • PCH 3.3B
  • IPO Year
  • HAE 1991
  • PCH N/A
  • Fundamental
  • Price
  • HAE $51.35
  • PCH $40.46
  • Analyst Decision
  • HAE Buy
  • PCH Strong Buy
  • Analyst Count
  • HAE 10
  • PCH 6
  • Target Price
  • HAE $84.20
  • PCH $49.67
  • AVG Volume (30 Days)
  • HAE 901.8K
  • PCH 446.7K
  • Earning Date
  • HAE 11-06-2025
  • PCH 10-27-2025
  • Dividend Yield
  • HAE N/A
  • PCH 4.43%
  • EPS Growth
  • HAE 46.89
  • PCH 15.06
  • EPS
  • HAE 3.28
  • PCH 0.53
  • Revenue
  • HAE $1,346,046,000.00
  • PCH $1,056,523,000.00
  • Revenue This Year
  • HAE N/A
  • PCH $4.42
  • Revenue Next Year
  • HAE $6.50
  • PCH $3.61
  • P/E Ratio
  • HAE $15.60
  • PCH $76.72
  • Revenue Growth
  • HAE 0.91
  • PCH N/A
  • 52 Week Low
  • HAE $50.68
  • PCH $36.82
  • 52 Week High
  • HAE $94.99
  • PCH $48.12
  • Technical
  • Relative Strength Index (RSI)
  • HAE 27.41
  • PCH 50.77
  • Support Level
  • HAE $53.10
  • PCH N/A
  • Resistance Level
  • HAE $54.52
  • PCH $42.79
  • Average True Range (ATR)
  • HAE 1.22
  • PCH 0.94
  • MACD
  • HAE 0.33
  • PCH -1.70
  • Stochastic Oscillator
  • HAE 11.20
  • PCH 92.64

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: